<code id='84D6241096'></code><style id='84D6241096'></style>
    • <acronym id='84D6241096'></acronym>
      <center id='84D6241096'><center id='84D6241096'><tfoot id='84D6241096'></tfoot></center><abbr id='84D6241096'><dir id='84D6241096'><tfoot id='84D6241096'></tfoot><noframes id='84D6241096'>

    • <optgroup id='84D6241096'><strike id='84D6241096'><sup id='84D6241096'></sup></strike><code id='84D6241096'></code></optgroup>
        1. <b id='84D6241096'><label id='84D6241096'><select id='84D6241096'><dt id='84D6241096'><span id='84D6241096'></span></dt></select></label></b><u id='84D6241096'></u>
          <i id='84D6241096'><strike id='84D6241096'><tt id='84D6241096'><pre id='84D6241096'></pre></tt></strike></i>

          explore

          explore

          author:Wikipedia    Page View:77624
          Blue nerve cell surrounded by red antibodies. -- health coverage from STAT
          Adobe

          Belgian drugmaker Argenx said Monday that its antibody treatment called Vyvgart significantly delayed the progression of an autoimmune nerve disorder that causes people to lose feeling and muscle strength in the arms and legs.

          The positive outcome — a 61% reduction in the risk of relapse compared to a placebo — achieved the main goal of a Phase 3 clinical trial designed to demonstrate Vyvgart’s benefit for patients with chronic inflammatory demyelinating polyneuropathy, or CIDP.

          advertisement

          “We hit the bullseye,” said Argenx CEO Tim Van Hauwermeiren.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more
          Congress: Eradicate hepatitis C and reduce the deficit
          Congress: Eradicate hepatitis C and reduce the deficit

          AdobeCongressfacesahistoricopportunitytostampoutadiseasethatkillsthousandsofAmericanseachyearandsave

          read more
          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more

          CMS should re

          AdobeIn2011,theCentersforMedicareandMedicaidServicescreatedtheannualwellnessvisit(AWV),anewvisittype